Literature DB >> 8706278

[A study of relation between rheumatoid arthritis (RA) and blood stasis--the effect of acupuncture promoting blood circulation to remove blood stasis].

Z Sun1.   

Abstract

In this article, the clinical 31 cases patients with Rheumatoid artritis (RA) were observed and animal experiments were carried out on RA model rats and the treatment of acupuncture with combination of the different points was adopted. It was found that most of the 31 cases of RA patients had the signs of bloods stasis and abnormal hemorheology, statistical analysis indicated that there were significant differents between RA patients and healthy person. Red and swelling in joints of four limbs, ear and tail, clubbed toes, abnormal hemorheology, high in blood platelet aggregation and so on were found in model rats of RA, statistically, sinificant differents also exist between model rats of RA and healthy rats. The above indesexes in patients and model rats of RA were significantly improved after acupuncture treatment, which suggested that (1) there be a close relation between RA and blood stasis. (2) acupuncture play a role of promoting blood circulation to remove blood statis. (3) examination of hemorheology may be one of standards that development of RA and curative effect.

Entities:  

Mesh:

Year:  1995        PMID: 8706278

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  2 in total

1.  The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial.

Authors:  Seunghoon Lee; Yeeun Cho; Jihye Kim; Jung Won Kang; Ga Young Yoon; Jun-Hwan Lee; So-Young Jung; Ojin Kwon; Kyung-Min Shin; Jae-Dong Lee
Journal:  Trials       Date:  2018-09-03       Impact factor: 2.279

2.  Electro-acupuncture at acupoint ST36 reduces inflammation and regulates immune activity in Collagen-Induced Arthritic Mice.

Authors:  Yun-Kyoung Yim; Hyun Lee; Kwon-Eui Hong; Young-Il Kim; Byung-Ryul Lee; Chang-Gue Son; Jung-Eun Kim
Journal:  Evid Based Complement Alternat Med       Date:  2006-08-18       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.